Your browser doesn't support javascript.
loading
Estimating the percentage of European MSM eligible for PrEP: insights from a bio-behavioural survey in thirteen cities.
Cordioli, Maddalena; Gios, Lorenzo; Huber, Jörg W; Sherriff, Nigel; Folch, Cinta; Alexiev, Ivailo; Dias, Sónia; Nöstlinger, Christiana; Gama, Ana; Naseva, Emilia; Valkovicová Staneková, Danica; Marcus, Ulrich; Schink, Susanne Barbara; Rosinska, Magdalena; Blondeel, Karel; Toskin, Igor; Mirandola, Massimo.
Afiliação
  • Cordioli M; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy maddalena.cordioli@univr.it.
  • Gios L; Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Huber JW; School of Health Sciences, University of Brighton, Brighton, UK.
  • Sherriff N; School of Health Sciences, University of Brighton, Brighton, UK.
  • Folch C; Centre for Epidemiological Studies on Sexually Transmitted Infections and HIV/AIDS of Catalonia (CEEISCAT), Catalonia Public Health Agency (ASPCAT), Badalona, Spain - Biomedical Research Networking Centre in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Alexiev I; National Reference Confirmatory Laboratory of HIV, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • Dias S; NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Centre, Universidade Nova de Lisboa, Lisboa, Lisboa, Portugal.
  • Nöstlinger C; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
  • Gama A; NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Centre, Universidade Nova de Lisboa, Lisboa, Lisboa, Portugal.
  • Naseva E; Ministry of Health, Program "Prevention and control of HIV/AIDS", Sofia, Bulgaria.
  • Valkovicová Staneková D; NRC for HIV/AIDS Prevention, Slovak Medical University, Bratislava, Slovakia.
  • Marcus U; Department of Infectious Diseases Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Schink SB; Department of Infectious Diseases Epidemiology, Robert Koch Institute, Berlin, Germany.
  • Rosinska M; Department of Infectious Disease Epidemiology and Surveillance, National Institute of Public Health-National Institute of Hygiene, Warszawa, Poland.
  • Blondeel K; Faculty of Medicine and Health Sciences, Ghent University, Gent, Belgium.
  • Toskin I; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Mirandola M; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Sex Transm Infect ; 97(7): 534-540, 2021 11.
Article em En | MEDLINE | ID: mdl-33441447
ABSTRACT

OBJECTIVES:

This paper aims to estimate the percentage of European men who have sex with men (MSM) who may benefit from pre-exposure prophylaxis (PrEP), applying the three most widely used HIV risk indices for MSM (MSM Risk Index, Menza score, San Diego Early Test (SDET) score) and drawing on a large-scale multisite bio-behavioural survey (Sialon II).

METHODS:

The Sialon II study was a bio-behavioural survey among MSM implemented in 13 European cities using either time-location sampling or respondent-driven sampling. Biological and behavioural data from 4901 MSM were collected. Only behavioural data of HIV-negative individuals were considered. Three widely used risk indices to assess HIV acquisition risk among MSM were used to estimate individual HIV risk scores and PrEP eligibility criteria.

RESULTS:

4219 HIV-negative MSM were considered. Regardless the HIV risk score used and the city, percentages of MSM eligible for PrEP were found to range between 5.19% and 73.84%. Overall, the MSM Risk Index and the Menza score yielded broadly similar percentages, whereas the SDET Index provided estimates constantly lower across all cities. Although all the three scores correlated positively (r>0.6), their concordance was highly variable (0.01CONCLUSION: Our findings showed the impact of different scoring systems on the estimation of the percentage of MSM who may benefit from PrEP in European cities. Although our primary aim was not to compare the performance of different HIV risk scores, data show that a considerable percentage of MSM in each city should be offered PrEP in order to reduce HIV infections. As PrEP is highly effective at preventing HIV among MSM, our findings provide useful, practical guidance for stakeholders in implementing PrEP at city level to tackle HIV infections in Europe.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Sexual / Aceitação pelo Paciente de Cuidados de Saúde / Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Profilaxia Pré-Exposição Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento Sexual / Aceitação pelo Paciente de Cuidados de Saúde / Infecções por HIV / Homossexualidade Masculina / Fármacos Anti-HIV / Profilaxia Pré-Exposição Idioma: En Ano de publicação: 2021 Tipo de documento: Article